The strongest momentum is currently coming from three overlapping categories: PCOS-support supplements, metabolic-health products influenced by the GLP-1 boom, and functional food and beverage formulations designed around long-term wellness positioning
Compounded medications may have variability in concentration and require more careful dose measurement
It covers 24 peptides with three dosing tiers: beginner (start here), standard (most common), and advanced (experienced users only)
Five percent of body weight is a clinically significant threshold, the point where health markers like blood pressure, blood sugar, and cholesterol typically start improving
Next-Generation Therapies Shift toward oral GLP-1 pills (no injections) Development of dual and triple agonists (GLP-1 + GIP combinations) Expansion into cardiovascular, kidney, and metabolic diseases 3
In head-to-head comparisons, tirzepatide has consistently shown greater average weight loss than semaglutide